Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TELMIN SYRINGE FORMULA DIN 00755788

Status: Cancelled Post Market
Holder: JANSSEN PHARMACEUTICA N.V.
Molecule: MEBENDAZOLE

Health Canada record

Active ingredient(s)MEBENDAZOLE 200 MG
Dosage formPaste
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1992
Current status date01-Aug-2012
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Pharmaceutica — licence , not currently licensed, last inspection rating C (2025-05-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MEBENDAZOLE

DINProductCompanyFormStrengthStatus
00556734VERMOXJANSSEN INCTabletMEBENDAZOLE 100 MGMarketed
02243944BOT-PLUS SYRINGE FORMULA EQUINE WORMERCAN-VET ANIMAL HEALTH SUPPLIES LTD.PasteMEBENDAZOLE 100 MG; TRICHLORFON 459 MGDormant
00540773EQUIVERM 200MG/GMDAVIS AND LAWRENCE CO.PowderMEBENDAZOLE 200 MGCancelled Post Market
00540765EQUIVERM B PSTDAVIS AND LAWRENCE CO.PowderMEBENDAZOLE 100 MG; TRICHLORFON 459 MGCancelled Post Market
00755796TELMIN B SYRINGE FORMULAJANSSENPasteMEBENDAZOLE 100 MG; TRICHLORFON 459 MGCancelled Post Market
00889148WORM-AWAY IVSERGEANTS OF CANADATabletMEBENDAZOLE 100 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
99082008-11-27New Drug Submission (NDS)CHANGE IN DIN OWNERSHIP

International API supply for MEBENDAZOLE

6 active FDA Drug Master Files.

Request a quote for TELMIN SYRINGE FORMULA

How to read a Canadian DIN record